Metabolic and Bariatric Surgery · 18 July 2024

Bariatric Surgery Decreases PAI-1 Levels and Improves Metabolic Markers

Bariatric surgery significantly lowers PAI-1 levels, which correlate with improvements in lipids, glucose, and insulin resistance. The surgery also induces a decrease in body weight and BMI, and helps reverse type 2 diabetes. PAI-1 acts as a regulator of PCSK9, TG, and BMI, while PCSK9 modulates LDL-C, HDL-C, and PAI-1. These changes suggest an improved balance in cholesterol and a reduction in factors contributing to atherosclerosis and cardiovascular disease in obesity.

Journal Article by Castro-Leyva V, Manuel-Apolinar L (…) Martínez-Murillo C et 4 al. in Arch Med Res

read the whole article in Arch Med Res

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

Ann Surg13 Jul 2026

Predictive Models Enhance Diabetes Remission After Surgery

A new calculator predicts type 2 diabetes remission outcomes for patients post-metabolic surgery, improving patient selection.

Ann Surg16 Jun 2026

EndoBarrier Shows Promise for Type 2 Diabetes in Obesity

Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.

All papers in Metabolic and Bariatric Surgery →